Search Results
Found 59 results for label/Opini.
Success Factors for eCTD Implementation in Mainland China and Taiwan
PPD experts discuss advances for eCTD implementation in mainland China and Taiwan and detail three critical success factors for readiness.
The Complementary Roles of Wearables and Patient-Reported Outcomes in Patient-Focused Drug Development: Spotlight on Oncology Trials
Researchers incorporating wearables into their work should think of them as complementing — rather than replacing — insights from PROs.
More sites seek ‘partner of choice’ label
Rhonda Henry says sponsors and CROs are looking for shared commitment, consistency and predictability when selecting a partner of choice.
Critical Care
We understand the unique nature of clinical studies in a critical care environment and ensure the quality of your development program.
Oncology and Hematology
Extensive knowledge of hematology and oncology cro research, vast capabilities and experience with feasibility studies and a large investigator network.
Our 4i Values
Integrity We work with Integrity by honoring commitments, communicating openly and demonstrating the highest ethical standards. We bring this to…
Positive Changes in the Latin American Clinical Trial Regulatory Environment
Andres Bayona, executive director in clinical monitoring and regional head of Latin America, and Mercedes Ponce de Leon, senior manager in regulatory affairs, discuss the clinical trial regulatory landscape in Latin America.
Major Clinical Trial Reforms Underway in China’s Regulatory Environment
Bill Wang, director of regulatory affairs, discusses China’s regulatory environment in the second-largest pharmaceutical market in the world.